Lofton launched a content seriesThe Dish on GLP-1sto help address common questions and issues
Wegovy, Zepbound, and Foundayo are not cancer treatments and should not be used as one
We have the logistics in place for worldwide distribution.
SmithRxs Approach to GLP-1 Management At SmithRx, we recognize being sustainable with GLP-1s requires balancing clinical oversight and cost-effectiveness
Novos GLP-1 Ozempic was already one of the top-selling drugs of 2023, with the companys GLP-1 drugs bringing in a combined $18.4 billion in sales, nearly double 2022 sales of $9.3 billion
However, their effects on bone integrity remain complex, with some evidence indicating bone-protective mechanisms while others suggest potential increases in bone resorption associated with weight loss